Identification of Chaetocin as a Potent non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 10 (16) , 3678-3690
Abstract
Chaetocin, a natural product extracted from Chaetomium species, possesses anticancer effects in several kinds of tumors. However, it remains unclear whether the potential indication for chaetocin could also include human gastric cancer. We found here that chaetocin induced caspase-dependent and -independent apoptosis in human gastric cancer cell lines, which greatly depended on BID-mediated AIF translocation. Despite not increasing the intercellular ROS levels in gastric cancer cells, chaetocin did cause a reduction in mitochondrial membrane potential probably through its regulation on the expression of Bcl-2 and BAX. Chaetocin could also induce autophagy in gastric cancer cells; blocking autophagy by chloroquine enhanced the cytotoxicity of chaetocin. Chaetocin was further found to suppress the growth of gastric cancer xenograft in nude mice. Therefore, our study provides first evidence that chaetocin has an anticancer efficacy against gastric cancer and the combined use of chaetocin with autophagy inhibitors may enhance the therapeutic effect for gastric cancer. As chronic and exorbitant ROS levels instigate drug resistance, chaetocin, which eradicates gastric cancer cells without increasing ROS levels, may initiate a new line of non-ROS-mediated anti-tumor strategy.Keywords
This publication has 36 references indexed in Scilit:
- The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferationBritish Journal of Cancer, 2011
- BID regulates AIF-mediated caspase-independent necroptosis by promoting BAX activationCell Death & Differentiation, 2011
- Apoptosis-Inducing Factor: Structure, Function, and Redox RegulationAntioxidants & Redox Signaling, 2011
- Preferential killing of cancer cells with mitochondrial dysfunction by natural compoundsMitochondrion, 2010
- Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiolsJournal of Cellular Biochemistry, 2010
- Methods in Mammalian Autophagy ResearchCell, 2010
- AMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cellsJournal of Cellular and Molecular Medicine, 2009
- The BCL-2 protein family: opposing activities that mediate cell deathNature Reviews Molecular Cell Biology, 2008
- The role of autophagy in cancer development and response to therapyNature Reviews Cancer, 2005
- Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspasesCurrent Opinion in Cell Biology, 2004